Companydirectory

Directory Search Results

Competition Date: Spring 2017

Aidence BV - Lung cancer screening pathway powered by Artificial Intelligence

Aidence provides Artificial Intelligence (AI) solutions for analyses of medical images and data. Lung CAD (L-CAD) is the company’s first CE-certified software providing highly accurate detection and...

• Funding £100,000
• Competition Cancer
• Competition Date Spring 2017
• Local AHSN Please Select
• Status In Development

• Cancer
• Digital/ICT/Mobile Solutions

---

C the Signs Limited - C the Signs - Fighting Cancer with Early Diagnosis

By 2020 one in two people in the UK will be diagnosed with Cancer at some point in their life. Approximately 50% will be diagnosed late, with an associated 80% mortality. Our innovation, C the Signs, ...

• Funding £1,099,519
• Competition Cancer
• Competition Date Spring 2017
• Local AHSN Eastern AHSN
• Status On Market

• Cancer
• Digital/ICT/Mobile Solutions

---

Cambridge Oncometrix Limited - Prostate Liquid Biopsy Test for Risk Stratificatio for Prostate Cancer

Cambridge Oncometrix is developing a non-invasive Prostate Liquid Biopsy test for risk stratification of men suspected of prostate cancer. The test measures the chemical element profile of semen, whic...

• Funding £1,099,284
• Competition Cancer
• Competition Date Spring 2017
• Local AHSN Eastern AHSN
• Status Proof of Concept

• Cancer
• In-vitro Diagnostics

---

Chromition Limited - Digital High Throughput Screening Platform for Rapid Cancer Diagnosis

Chromition's technology is a digital pathology platform that enables rapid diagnosis of cancer. This project will validate the technology in a clinical setting with the end point of accelerating diagn...

• Funding £988,870
• Competition Cancer
• Competition Date Spring 2017
• Local AHSN Greater Manchester AHSN
• Status In Development

• Cancer
• Digital/ICT/Mobile Solutions

---

Corporate Health International UK Ltd - Creating highly automated, primary-care delivered video capsule endoscopy diagnostics

Optical colonoscopy (OC) is the main bottleneck for bowel cancer diagnosis. Video Capsule Endoscopy (VCE) can replace many investigative OCs. It can be on par or better in medical accuracy. It can be ...

• Funding £98,740
• Competition Cancer
• Competition Date Spring 2017
• Local AHSN North East & North Cumbria AHSN
• Status Proof of Concept

• Cancer
• In-vitro Diagnostics

---

DeepMed IO - Deep learning powered metastases detection system for digital pathology

More than 13,000 UK cancer patients wait too long for treatment due to a diagnostic bottleneck. Detection of metastases in stained lymph-node sections requires large amount of reading time from pathol...

• Funding £1,072,972
• Competition Cancer
• Competition Date Spring 2017
• Local AHSN Greater Manchester AHSN
• Status In Development

• Cancer
• Digital/ICT/Mobile Solutions

---

FaHRAS - FaHRAS Cancer Risk Assessment Software

FaHRAS supplies a sophisticated evidence-based software system which enables a user to run a variety of analyses against their family history to quantify their risk of developing cancer.

• Funding £99,976
• Competition Cancer
• Competition Date Spring 2017
• Local AHSN East Midlands AHSN
• Status In Development

• Cancer
• Digital/ICT/Mobile Solutions

---

Oncimmune Limited - EarlyCDT-Lung+ for Cancer Risk Stratification of Indeterminate Pulmonary Nodules

Oncimmune aims to develop EarlyCDT-Lung+ as a test to help with the earlier identification of lung cancer in patients with indeterminate pulmonary nodules (IPNs). The resulting new blood test will ena...

• Funding £94,000
• Competition Cancer
• Competition Date Spring 2017
• Local AHSN East Midlands AHSN
• Status In Development

• Cancer
• In-vitro Diagnostics

---

Skin Analytics Ltd - Expansion of Skin Cancer Diagnosis Service

Skin Analytics has already developed an AI melanoma screening tool for use assessing pigmented lesions in primary care and earlier. Two additional technologies could, when coupled with our existing me...

• Funding £99,941
• Competition Cancer
• Competition Date Spring 2017
• Local AHSN Imperial College Health Partners AHSN
• Status In Development

• Cancer
• Digital/ICT/Mobile Solutions

---

VODCA Limited - Augmented Microbiome-Mediated Breath Test for Earlier Oesophago-Gastric Cancer Diagnosis (AMBEC)

Oesophago-gastric cancer is among the world's top five cancers. Survival rates are very poor, the disease presents late and early symptoms are non-specific. We have developed a non-invasive test for o...

• Funding £100,000
• Competition Cancer
• Competition Date Spring 2017
• Local AHSN Imperial College Health Partners AHSN
• Status Please Select

• Cancer
• In-vitro Diagnostics

---